Alector
ALEC | NASDAQ
$2.56
-$0.01 (-0.39%)
At close: Nov 17, 2026, 4:00 PM ET
$2.50
-$0.06 (-2.27%)
After-hours:
Nov 17, 2026, 7:30 PM ET
Alector Company Profile
Company profile explainedCompany Profile
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
Key Executives
| Name | Position |
|---|---|
| Arnon Rosenthal | Co-Founder, Chief Executive Officer & Director |
| Caiyan Li | Head of Clinical Development & Data Science |
| Clare Hunt | Chief People & Places Officer |
| Danielle Pasqualone | General Counsel |
| Eric Brown | Director of Antibody Discovery & Protein Engineering |
| Hua Long DABT | Senior VP & Head of Research |
| Katie Hogan | Senior Director of Corporate Communication & Investor Relations |
| Neil Berkley | CFO & Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 26, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Oct 23, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Oct 16, 2026 | 424B5 | Filing |
| Oct 16, 2026 | 8-K | Current Report |
| Oct 16, 2026 | FWP | Filing |
| Oct 15, 2026 | 4 | Filing |
| Oct 15, 2026 | 4 | Filing |
| Oct 15, 2026 | 4 | Filing |
| Oct 14, 2026 | 8-K | Current Report |
| Oct 05, 2026 | 8-K | Current Report |
Alector
| Country | United States |
| IPO Date | Feb 7, 2019 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 103 |
| CEO | Arnon Rosenthal |
Contact Details
131 Oyster Point Boulevard South San Francisco,
California 94080 United States
Stock Details
| Ticker Symbol | ALEC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001653087 |
| CUSIP Number | 014442107 |
| ISIN Number | US0144421072 |
| SIC Code | 2836 |
Add to Watchlist
Select watchlists to add or remove ALEC